| Followers | 236 |
| Posts | 10817 |
| Boards Moderated | 0 |
| Alias Born | 07/17/2006 |
Saturday, June 14, 2014 10:39:54 AM
Chica..
Dr. Libby of the Brigham in Boston paints a beautiful picture of the inflammatory nature of atheroscerotic heart disease (AHD), but tragically there is an immense gaping hole in his knowledge of the disease.
If the cause of AHD is compared to the "Creationists vs the Evolutionists, with the lipidologist being the creationists, and the inflammationists being the evolutionists, then Dr. Libby is trying to rationalise evolution (inflammation) in terms of creation.
Dr. Libby argues that the thirty year siege on what constitutes healthy cholesterol levels which he feels now should be LDL-C levels under 100 (down from 300), are a failure on the part of doctors to understand just how bad LDL-C really is. As such, he is a "Statinista," firmly in the creation camp.
Furthermore he blindly rationalizes the fact that the LDL-C figures do not jive with the clinical reality that over 50% 0f heart attacks come with "normal" LDL-Cs; by saying that minor infections raise systemic inflammation which tips the boat. He must think populations like the Japanese, which have low AHD, do not get colds or viruses.
It is clear the Dr. knows nothing about the eicosanoid system, or the anti-inflammatory effect of EPA in sufficient dosages.
":>) JL
Dr. Libby of the Brigham in Boston paints a beautiful picture of the inflammatory nature of atheroscerotic heart disease (AHD), but tragically there is an immense gaping hole in his knowledge of the disease.
If the cause of AHD is compared to the "Creationists vs the Evolutionists, with the lipidologist being the creationists, and the inflammationists being the evolutionists, then Dr. Libby is trying to rationalise evolution (inflammation) in terms of creation.
Dr. Libby argues that the thirty year siege on what constitutes healthy cholesterol levels which he feels now should be LDL-C levels under 100 (down from 300), are a failure on the part of doctors to understand just how bad LDL-C really is. As such, he is a "Statinista," firmly in the creation camp.
Furthermore he blindly rationalizes the fact that the LDL-C figures do not jive with the clinical reality that over 50% 0f heart attacks come with "normal" LDL-Cs; by saying that minor infections raise systemic inflammation which tips the boat. He must think populations like the Japanese, which have low AHD, do not get colds or viruses.
It is clear the Dr. knows nothing about the eicosanoid system, or the anti-inflammatory effect of EPA in sufficient dosages.
":>) JL
Recent AMRN News
- Amarin Highlights New REDUCE-IT Analysis Showing Risk-Weighted ApoB May Improve Cardiovascular Risk Detection (AMRN) • IH Market News • 05/27/2026 03:24:38 PM
- New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia • GlobeNewswire Inc. • 05/27/2026 12:00:00 PM
- Earnings Report Shows Narrowing Losses as Amarin (AMRN) Advances Partner-Led Growth Strategy • IH Market News • 04/29/2026 02:19:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/29/2026 11:06:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 11:05:15 AM
- Amarin Reports 2026 First Quarter Financial Results • GlobeNewswire Inc. • 04/29/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:02 PM
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
